202 related articles for article (PubMed ID: 1927681)
1. Effect of stress on glucoregulation in physiology and diabetes.
Vranic M; Miles P; Rastogi K; Yamatani K; Shi Z; Lickley L; Hetenyi G
Adv Exp Med Biol; 1991; 291():161-83. PubMed ID: 1927681
[TBL] [Abstract][Full Text] [Related]
2. Catecholamine responses and their interactions with other glucoregulatory hormones.
Vranic M; Gauthier C; Bilinski D; Wasserman D; El Tayeb K; Hetenyi G; Lickley HL
Am J Physiol; 1984 Aug; 247(2 Pt 1):E145-56. PubMed ID: 6147092
[TBL] [Abstract][Full Text] [Related]
3. Intracerebroventricular administration of somatostatin octapeptide counteracts the hormonal and metabolic responses to stress in normal and diabetic dogs.
Miles PD; Yamatani K; Brown MR; Lickley HL; Vranic M
Metabolism; 1994 Sep; 43(9):1134-43. PubMed ID: 7916119
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of glucoregulatory responses to stress and their deficiency in diabetes.
Miles PD; Yamatani K; Lickley HL; Vranic M
Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1296-300. PubMed ID: 1996330
[TBL] [Abstract][Full Text] [Related]
5. Role of epinephrine-mediated beta-adrenergic mechanisms in hypoglycemic glucose counterregulation and posthypoglycemic hyperglycemia in insulin-dependent diabetes mellitus.
Popp DA; Shah SD; Cryer PE
J Clin Invest; 1982 Feb; 69(2):315-26. PubMed ID: 6120181
[TBL] [Abstract][Full Text] [Related]
6. Important role of adrenergic mechanisms in acute glucose counterregulation following insulin-induced hypoglycemia in type I diabetes. Evidence for an effect mediated by beta-adrenoreceptors.
Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P
Diabetes; 1982 Jul; 31(7):641-7. PubMed ID: 6298039
[TBL] [Abstract][Full Text] [Related]
7. Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion.
Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P; Gerich JE
Diabetes; 1983 Feb; 32(2):134-41. PubMed ID: 6337896
[TBL] [Abstract][Full Text] [Related]
8. Phlorizin-induced normoglycemia partially restores glucoregulation in diabetic dogs.
Hetenyi G; Gauthier C; Byers M; Vranic M
Am J Physiol; 1989 Feb; 256(2 Pt 1):E277-83. PubMed ID: 2645787
[TBL] [Abstract][Full Text] [Related]
9. Effect of opiate-receptor blockade on normoglycemic and hypoglycemic glucoregulation.
el-Tayeb KM; Brubaker PL; Lickley HL; Cook E; Vranic M
Am J Physiol; 1986 Mar; 250(3 Pt 1):E236-42. PubMed ID: 3006509
[TBL] [Abstract][Full Text] [Related]
10. Glucose counterregulation, hypoglycemia, and intensive insulin therapy in diabetes mellitus.
Cryer PE; Gerich JE
N Engl J Med; 1985 Jul; 313(4):232-41. PubMed ID: 2861565
[TBL] [Abstract][Full Text] [Related]
11. Glucose uptake during centrally induced stress is insulin independent and enhanced by adrenergic blockade.
Lekas MC; Fisher SJ; El-Bahrani B; van Delangeryt M; Vranic M; Shi ZQ
J Appl Physiol (1985); 1999 Aug; 87(2):722-31. PubMed ID: 10444633
[TBL] [Abstract][Full Text] [Related]
12. Beta-endorphin modulation of the glucoregulatory effects of repeated epinephrine infusion in normal dogs.
el-Tayeb KM; Brubaker PL; Vranic M; Lickley HL
Diabetes; 1985 Dec; 34(12):1293-300. PubMed ID: 2998913
[TBL] [Abstract][Full Text] [Related]
13. State of metabolic control determines role of epinephrine-glucagon interaction in glucoregulation in diabetes.
Kemmer FW; Lickley HL; Gray DE; Perez G; Vranic M
Am J Physiol; 1982 Jun; 242(6):E428-36. PubMed ID: 6124126
[TBL] [Abstract][Full Text] [Related]
14. Beta endorphin modulation of the glucoregulatory effects of repeated epinephrine infusion in alloxan-diabetic and normal dogs.
el-Tayeb KM; Vranic M; Brubaker PL; Lickley HL
Diabetologia; 1987 Sep; 30(9):745-54. PubMed ID: 2962893
[TBL] [Abstract][Full Text] [Related]
15. Beta-blockade, but not normoglycemia or hyperinsulinemia, markedly diminishes stress-induced hyperglycemia in diabetic dogs.
Rashid S; Shi ZQ; Niwa M; Mathoo JM; Vandelangeryt ML; Bilinski D; Lewis GF; Vranic M
Diabetes; 2000 Feb; 49(2):253-62. PubMed ID: 10868942
[TBL] [Abstract][Full Text] [Related]
16. Opiate blockade enhances hypoglycemic counterregulation in normal and insulin-dependent diabetic subjects.
Caprio S; Gerety G; Tamborlane WV; Jones T; Diamond M; Jacob R; Sherwin RS
Am J Physiol; 1991 Jun; 260(6 Pt 1):E852-8. PubMed ID: 2058661
[TBL] [Abstract][Full Text] [Related]
17. Molecular reductions in glucokinase activity increase counter-regulatory responses to hypoglycemia in mice and humans with diabetes.
Chakera AJ; Hurst PS; Spyer G; Ogunnowo-Bada EO; Marsh WJ; Riches CH; Yueh CY; Markkula SP; Dalley JW; Cox RD; Macdonald IA; Amiel SA; MacLeod KM; Heisler LK; Hattersley AT; Evans ML
Mol Metab; 2018 Nov; 17():17-27. PubMed ID: 30146176
[TBL] [Abstract][Full Text] [Related]
18. Paradoxical reduction in pancreatic glucagon with normalization of somatostatin and decrease in insulin in normoglycemic alloxan-diabetic dogs: a putative mechanism of glucagon irresponsiveness to hypoglycemia.
Rastogi KS; Lickley L; Jokay M; Efendic S; Vranic M
Endocrinology; 1990 Feb; 126(2):1096-104. PubMed ID: 1967577
[TBL] [Abstract][Full Text] [Related]
19. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
Rizza RA; Cryer PE; Gerich JE
J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413
[TBL] [Abstract][Full Text] [Related]
20. Relevance of glucose counterregulatory systems to patients with diabetes: critical roles of glucagon and epinephrine.
Cryer PE; Gerich JE
Diabetes Care; 1983; 6(1):95-9. PubMed ID: 6341018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
